Andrew Mant
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 5
- Peptidase Inhibition and Analysis 3
- Colorectal Cancer Treatments and Studies 2
-
- Prostate Cancer Treatment and Research 5
- Co-authors
- Phillip Parente (8 shared papers)Victoria Atkinson (3 shared papers)Georgina V. Long (3 shared papers)Danny Rischin (1 shared paper)Andrew Haydon (2 shared papers)Robert M. Mason (2 shared papers)Alexander M. Menzies (2 shared papers)Heidi Fettke (5 shared papers)
In The Last Decade
Andrew Mant
16 papers receiving 128 citations
Peers
Comparison fields: 5 of 27
- Oncology 88
- Cancer Research 27
- Immunology 36
- Pulmonary and Respiratory Medicine 32
- Molecular Biology 43
Countries citing papers authored by Andrew Mant
This map shows the geographic impact of Andrew Mant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Mant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Mant more than expected).
Fields of papers citing papers by Andrew Mant
This network shows the impact of papers produced by Andrew Mant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Mant. The network helps show where Andrew Mant may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Mant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 38 | |
| 2 | 2018 | 24 | |
| 3 | 2021 | 17 | |
| 4 | 2020 | 13 | |
| 5 | 2019 | 11 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 6 | |
| 8 | 2021 | 3 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 2 | |
| 11 | Plasma Cell-Free DNA (cfDNA) Concentration and Outcomes in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Patients Treated with Androgen Receptor Signalling Inhibitors (ARSIs) | 2018 | 1 |
| 12 | 2024 | 1 | |
| 13 | 2023 | 1 | |
| 14 | 2018 | 1 | |
| 15 | 2021 | 1 | |
| 16 | 2018 | 1 |
About Andrew Mant
Andrew Mant is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 16 papers that have together received 130 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Prostate Cancer Treatment and Research (5 papers), CAR-T cell therapy research (5 papers), Peptidase Inhibition and Analysis (3 papers), Cancer Genomics and Diagnostics (3 papers), Melanoma and MAPK Pathways (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (88 citations), Cancer Research (27 citations), Immunology (36 citations), Pulmonary and Respiratory Medicine (32 citations) and Molecular Biology (43 citations). Andrew Mant has collaborated with scholars based in Australia, Hong Kong and China. Frequent co-authors include Phillip Parente, Victoria Atkinson, Georgina V. Long, Danny Rischin, Andrew Haydon, Robert M. Mason, Alexander M. Menzies, Heidi Fettke, Balasubramanian Krishnamurthy and Shahneen Sandhu. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, European Urology Focus, Cancer and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.